---
figid: PMC4337027__nihms-659350-f0001
figtitle: Stable isotope-resolved metabolomics (SIRM) pipelines
organisms:
- NA
pmcid: PMC4337027
filename: nihms-659350-f0001.jpg
figlink: /pmc/articles/PMC4337027/figure/F1/
number: F1
caption: 'Stable isotope-resolved metabolomics (SIRM) pipelines. Redrawn from ref
  (). SIRM approach is implemented by administering stable isotope tracers such as
  uniformly 13C-labeled glucose (13C6-Glc) or uniformly 13C,15N-labeled glutamine
  (13 C5,15N2-Gln) to cell cultures, excised tissues, animals, and even human subjects.
  Therapeutic agents can be included in the treatment to observe their impact on the
  metabolic networks. The tracers are allowed to be metabolized in situ for a period
  appropriate to the experimental design, followed by cell harvest or tissue resection
  via surgery. Polar and lipophilic metabolites are extracted and analyzed by NMR
  and MS for labeling patterns of various metabolites. Illustrated are the 1-D 1H-11-47
  HSQC NMR spectra of polar extracts acquired from control and cisplatin-treated human
  lung adenocarcinoma A549 cells (A) and the high-resolution exact mass FT-ICR-MS
  spectra of lipid extracts obtained from control and selenite-treated A549 cells
  grown in 13C6-Glc tracer (B). M+3: represents excess of three 13C neutron masses,
  which corresponds to 13C3-glycerol backbone; PI: phosphatidylinositol; curved dashed
  arrows: cleavage of fatty acyl chains by tandem MS to confirm C18:0 (stearate) and
  C20:4 (arachidonate) acyl chain composition. Peaks with exact mass higher than M+3
  in the insets are derived from 13C-labeled fatty acyl chains. They are greatly reduced
  under selenite treatment.'
papertitle: Stable Isotope Labeled Tracers for Metabolic Pathway Elucidation by GC-MS
  and FT-MS.
reftext: Richard M. Higashi, et al. Methods Mol Biol. ;1198:147-167.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5749215
figid_alias: PMC4337027__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC4337027__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4337027__nihms-659350-f0001.html
  '@type': Dataset
  description: 'Stable isotope-resolved metabolomics (SIRM) pipelines. Redrawn from
    ref (). SIRM approach is implemented by administering stable isotope tracers such
    as uniformly 13C-labeled glucose (13C6-Glc) or uniformly 13C,15N-labeled glutamine
    (13 C5,15N2-Gln) to cell cultures, excised tissues, animals, and even human subjects.
    Therapeutic agents can be included in the treatment to observe their impact on
    the metabolic networks. The tracers are allowed to be metabolized in situ for
    a period appropriate to the experimental design, followed by cell harvest or tissue
    resection via surgery. Polar and lipophilic metabolites are extracted and analyzed
    by NMR and MS for labeling patterns of various metabolites. Illustrated are the
    1-D 1H-11-47 HSQC NMR spectra of polar extracts acquired from control and cisplatin-treated
    human lung adenocarcinoma A549 cells (A) and the high-resolution exact mass FT-ICR-MS
    spectra of lipid extracts obtained from control and selenite-treated A549 cells
    grown in 13C6-Glc tracer (B). M+3: represents excess of three 13C neutron masses,
    which corresponds to 13C3-glycerol backbone; PI: phosphatidylinositol; curved
    dashed arrows: cleavage of fatty acyl chains by tandem MS to confirm C18:0 (stearate)
    and C20:4 (arachidonate) acyl chain composition. Peaks with exact mass higher
    than M+3 in the insets are derived from 13C-labeled fatty acyl chains. They are
    greatly reduced under selenite treatment.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ci
  - se
  - min
  - mnb
  - .na.character
  - H15
  - Nmdar1
  - Ms
  - wapl
  - pi
  - Selenite
---
